NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2 | -$7 | -$3 | – |
| Dep. & Amort. | $0 | $0 | $0 | – |
| Deferred Tax | -$0 | -$2 | $1 | – |
| Stock-Based Comp. | $0 | $2 | $1 | – |
| Change in WC | $1 | $0 | -$0 | – |
| Other Non-Cash | $0 | -$0 | $0 | – |
| Operating Cash Flow | -$1 | -$6 | -$1 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | $0 | -$0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | $0 | – |
| Other Inv. Act. | $0 | $0 | $0 | – |
| Investing Cash Flow | $0 | $0 | $0 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | – |
| Stock Issued | $0 | $5 | $1 | – |
| Stock Repurch. | $0 | $0 | $0 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $0 | $6 | $1 | – |
| Financing Cash Flow | $0 | $6 | $1 | – |
| Forex Effect | $0 | $0 | $0 | – |
| Net Chg. in Cash | -$1 | $1 | -$0 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $0 | $0 | – |
| End Cash | $0 | $1 | $0 | – |
| Free Cash Flow | -$1 | -$6 | -$1 | – |